CPHI 2026 – 23/07/2026
PCI Drug-Device 28/05/2026
Media Pack
News

Current Edition

Volume 18 Issue 2
ramusmedical
Asia Pacific

Korea’s ViroMed acquires DNA-producing facility for clinical trial in U.S.

ViroMed, a Korean developer of biologic drugs, Wednesday announced it has acquired a DNA production facility in San Diego, California, adding a manufacturing function...
18 July 2018 Asia Pacific | Europe | North America clinical | DNA-producing
Continue Reading →
Europe

Sanofi to invest €350 million in Canadian vaccine facility

Expansion demonstrates company's commitment to innovation and leadership in global public health New Toronto facility is one of the largest-ever investments b...
18 April 2018 Europe | North America 350 million | facility
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte